Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections (Q42271966)

19 October 2017

title

Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections (English)

1 reference

19 October 2017

0 references

0 references

5

Henrik Zetterberg

1 reference

19 October 2017

4

Kaj Blennow

1 reference

19 October 2017

3

Staffan Nilsson

1 reference

19 October 2017

Anna Grahn

1

1 reference

19 October 2017

Lars Hagberg

series ordinal

2

1 reference

19 October 2017

Marie Studahl

series ordinal

6

1 reference

19 October 2017

publication date

8 March 2013

1 reference

19 October 2017

1 reference

19 October 2017

volume

260

1 reference

19 October 2017

issue

7

1 reference

19 October 2017

page(s)

1813-1821

1 reference

Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Quantitative real time PCR detection of Varicella-zoster virus DNA in cerebrospinal fluid in patients with neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Varicella-zoster virus CNS disease--viral load, clinical manifestations and sequels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Neuronal and glial cerebrospinal fluid protein biomarkers are elevated after West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Sequential analyses of neurobiochemical markers of cerebral damage in cerebrospinal fluid and serum in CNS infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Cerebrospinal fluid neurofilament and glial fibrillary acidic protein in patients with cerebral vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Prognostic value of biochemical markers of brain damage and oxidative stress in post-surgical aneurysmal subarachnoid hemorrhage patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Assessment of damage to the central nervous system by determination of S-100 protein in the cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Long-term outcome of patients presenting with acute infectious encephalitis of various causes in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Infectious encephalitis in france in 2007: a national prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Assessment of outcome after severe brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Herpes simplex encephalitis. An immunohistological study of the distribution of viral antigen within the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

MRI demonstration of Wallerian degeneration in various intracranial lesions and its clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Varicella zoster virus vasculopathy and disseminated encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

VZV vasculopathy associated with myelo-radiculoganglio-meningo-encephalitis: an autopsy case of an immunocompetent 66-year-old male.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5-1995 revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Varicella-zoster virus DNA in CSF and arteries in delayed contralateral hemiplegia: evidence for viral invasion of cerebral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Fatal varicella-zoster virus antigen-positive giant cell arteritis of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Thrombotic cerebral vasculopathy associated with herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Subarachnoid hemorrhage and granulomatous angiitis of the basilar artery: demonstration of the varicella-zoster-virus in the basilar artery lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

21 January 2018

Herpes zoster myelitis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Monitoring of herpes simplex virus DNA types 1 and 2 viral load in cerebrospinal fluid by real-time PCR in patients with herpes simplex encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6883-5

Astroglial and neuronal proteins in cerebrospinal fluid as markers of CNS involvement in Lyme neuroborreliosis

21 January 2018

1 reference

12 December 2020

Neuropathology of fatal varicella

1 reference

12 December 2020

Detection of varicella-zoster virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients suffering from neurological complications associated with chicken pox or herpes zoster

1 reference

12 December 2020

Herpes zoster ophthalmicus with contralateral hemiplegia: identification of cause

1 reference

12 December 2020

Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF.

1 reference

12 December 2020

Varicella zoster virus and central nervous system syndromes

1 reference

12 December 2020

Syndromes associated with immunodeficiency

1 reference

12 December 2020

10.1007/S00415-013-6883-5

Identifiers

DOI

1 reference

19 October 2017

1 reference